Micromet, Bayer preclinical data

In mouse xenograft models of prostate cancer, daily 0.05, 0.5 and 5 mg/kg IV MT112/BAY 2010112 significantly reduced mean tumor volume vs. vehicle-treated controls at day 16 (p<0.001 for all). Data we...